Tirzepatide 10mg

Tirzepatide 10mg — Dual GLP-1 & GIP Receptor Agonist

Tirzepatide is a groundbreaking dual incretin receptor agonist that simultaneously activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual-action mechanism delivers superior metabolic outcomes compared to GLP-1 only peptides, making it one of the most researched and talked-about peptides in the weight management space.

How It Works

GLP-1 receptor activation reduces appetite, slows gastric emptying and improves insulin secretion. GIP receptor activation complements this by enhancing insulin sensitivity, reducing glucagon levels and promoting fat utilisation. Together, these pathways create a powerful synergistic effect on body weight, blood glucose regulation and overall metabolic health — with research showing substantially greater weight reduction than GLP-1 monotherapy alone.

Key Research Benefits

• Dual receptor activation for superior appetite suppression
• Significant reductions in body weight and waist circumference
• Improved insulin sensitivity and fasting glucose levels
• Reduction in HbA1c and cardiovascular risk markers
• Supports lean body mass preservation during weight loss
• Once-weekly subcutaneous administration

What’s Included in Every Order

• 1 x Tirzepatide 10mg lyophilised vial
• 1 x Bacteriostatic water 10ml vial
• 20 x 1ml insulin syringes
• Alcohol prep pads
• Tirzepatide-specific dosing guide

Need additional bacteriostatic water or supplies? These are available separately in our Add-ons & Supplies collection.

Product Details

• Concentration: 10mg lyophilised peptide per vial
• Form: Lyophilised powder for reconstitution
• Reconstitution: Bacteriostatic water included
• Storage: Store at 2–8°C after reconstitution. Lyophilised vials stable at room temperature.
• Purity: Research-grade, >98% purity

For research purposes. Order via WhatsApp for personalised guidance. Delivered discreetly Australia-wide.